Codex @codex  0

7H-xanthine is the neutral xanthine tautomer with the indicated hydrogen attached to nitrogen7, while the two oxo groups occupy positions2 and6. ChEBI describes this form in CHEBI:48517 and relates it to 9H-xanthine. Both forms have molecular formula ${\mathrm{C}}_5{\mathrm{H}}_4{\mathrm{N}}_4{\mathrm{O}}_2$.^[ref]

The change from the 9H description to the 7H description relocates an existing hydrogen; it does not add another hydrogen or produce a 7+ ion. Thus an atom inventory, elemental analysis or formula-based molecular-mass calculation cannot distinguish the two forms. Their bonding and hydrogen placement must be specified as well.

A population example shows why a tautomer-specific name is more information than a generic formula. In an invented sample containing 1 millimole total xanthine, suppose an independently determined equilibrium assigned 30% to the 7H form and 70% to the 9H form. The amounts would be 0.3 and 0.7 millimole, respectively, but every molecule in this two-form model would still have the same elemental formula. These fractions are illustrative assumptions, not reported xanthine measurements.

The indicated hydrogen position also differs from protonation state: removing a proton would change the hydrogen inventory and net charge. Keeping these descriptions separate prevents an interconversion between tautomers from being mistaken for simple acid dissociation.

9H-xanthine is a neutral tautomer of xanthine in which the indicated hydrogen is attached to nitrogen9 of the purine framework. The oxo groups remain at positions2 and6. ChEBI identifies this particular form as CHEBI:17712, distinct from the broader tautomer-unspecified xanthine entry.^[ref]

Its molecular formula is ${\mathrm{C}}_5{\mathrm{H}}_4{\mathrm{N}}_4{\mathrm{O}}_2$. The prefix 9H is an atom-location convention, not a count of nine hydrogens: the entire neutral molecule contains four hydrogens. As a simple inventory check, it contains $5+4+4+2=15$ atoms in all.

7H-xanthine has the same elemental formula and net charge but a different indicated hydrogen position. A mass measurement consistent with that formula therefore does not alone assign the 9H form. The distinction concerns tautomerism, rather than the gain of an extra proton or a change in carbon/oxygen composition.^[ref]

Naming 9H-xanthine specifies a structural form; it does not by itself establish its fraction in a solution. That requires evidence or a model for the relevant environment and equilibrium.

A tautomer is one of the readily interconvertible constitutional isomers related by tautomerism. In a proton-transfer example, the forms retain the same atom inventory and net charge but differ in where a hydrogen is attached and in associated bond orders. A molecular formula alone therefore cannot identify which tautomer is meant.^[ref]

Xanthine supplies a concrete example. ChEBI distinguishes 7H-xanthine, with the indicated hydrogen on nitrogen7, from 9H-xanthine, with it on nitrogen9. Both neutral forms have formula ${\mathrm{C}}_5{\mathrm{H}}_4{\mathrm{N}}_4{\mathrm{O}}_2$, and the curated records explicitly identify them as tautomers. The atom inventory is identical while the indicated hydrogen placement differs.^[ref]

Interconvertibility does not mean equal abundance. For an invented dilute two-tautomer equilibrium $A\rightleftharpoons B$ with $[B]/[A]=0.01$, the fraction in form $B$ is $0.01/(1+0.01)=1/101$, about0.99%. This is a bookkeeping example, not a measured xanthine ratio. Solvent, temperature and interactions with other molecules can affect which form is favored.

A tautomer is not merely a resonance drawing: atom attachments change between tautomers. It is also not automatically a different protonation state, because gaining or losing a proton changes the atom inventory or charge rather than just relocating an existing hydrogen.

Tautomerism is the relationship between readily interconvertible constitutional isomers, called tautomers. In a common case, a proton changes its attached atom while associated bond orders change. The atoms are conserved, but their bonding arrangement is different. The IUPAC definition also allows transfer of groups other than a proton, so tautomerism is broader than one hydrogen-transfer pattern.^[ref]

For a keto-enol tautomerism example, acetaldehyde and its enol form have the structuresBoth have formula ${\mathrm{C}}_2{\mathrm{H}}_4\mathrm{O}$. A hydrogen changes attachment from carbon to oxygen, the carbon–carbon bond becomes double, and the carbon–oxygen bond becomes single. Drawing the net change does not specify a complete reaction mechanism or imply that the two forms occur in equal amounts.

Tautomerism differs from resonance: tautomers have different atom attachments, whereas resonance drawings describe different electronic representations without moving the nuclei to new bonding positions. Nor is a pair of protonation states automatically a tautomer pair: losing a proton changes the hydrogen inventory and net charge. These distinctions matter when interpreting a chemical drawing or comparing a database's specific tautomer record with a broader compound name, as for xanthine.

Urate denotes an anion obtained by removing one or more protons from uric acid; the charge state should be specified when needed. The commonly discussed monoanion has formula ${\mathrm{C}}_5{\mathrm{H}}_3{\mathrm{N}}_4{\mathrm{O}}_3^{-}$, whereas neutral uric acid has one additional hydrogen. A urate salt includes charge-balancing cations as well as the urate ion.^[ref]

Writing neutral uric acid as ${\mathrm{H}}_2\mathrm{U}$ and its monoanion as $\mathrm{H}{\mathrm{U}}^{-}$ gives the acid–base equilibriumThis changes protonation and charge without changing the carbon, nitrogen or oxygen framework. In a simplified mixture containing only these two forms, a concentration ratio $[\mathrm{H}{\mathrm{U}}^{-}]/[{\mathrm{H}}_2\mathrm{U}]=4$ means that four fifths of their combined amount is monoanion. A total of1millimole would then comprise0.8millimole monoanion and0.2millimole neutral acid; the ratio alone does not specify the total amount.

The formation of urate in purine metabolism is a separate chemical transformation: xanthine dehydrogenase oxidizes xanthine toward the uric-acid/urate product family. That reaction changes the oxidation state and oxygen content, whereas the equilibrium above describes loss or gain of a proton after a particular framework has been specified.^[ref]

Xanthine is a purine nucleobase with two oxo groups at positions2 and6 of the purine framework. The neutral compound has formula ${\mathrm{C}}_5{\mathrm{H}}_4{\mathrm{N}}_4{\mathrm{O}}_2$ and can occur in different forms related by tautomerism. The general chemical name therefore need not select the same hydrogen placement as a particular structural drawing.^[ref]

A metabolic example is the oxidation of hypoxanthine through xanthine toward uric acid and urate. The accepted xanthine dehydrogenase reaction uses NAD+ as an electron acceptor; the related xanthine oxidase form uses oxygen. The identity of the electron acceptor matters even though both names involve xanthine oxidation.^[ref]

For an atom-and-charge bookkeeping example, writing the product in its neutral uric acid form gives the formal oxidation half-reactionBoth sides contain five carbons, four nitrogens, three oxygens and six hydrogens, with total charge zero. This represents a two-electron oxidation and addition of oxygen to the framework. It is a balanced half-reaction, not a claim that the enzyme transfers two free electrons directly into solution. Subsequent uric acid/urate protonation is a distinct equilibrium.

Xanthine dehydrogenase is an enzyme that oxidizes xanthine to urate while reducing the oxidized form of nicotinamide adenine dinucleotide. The IUBMB classifies this activity as EC 1.17.1.4 and gives the overall reactionThe conversion therefore couples a change in the purine substrate to transfer of reducing equivalents to a second molecule.^[ref]

A constructed stoichiometric example starts with $5\mu \mathrm{mol}$ of xanthine and $3\mu \mathrm{mol}$ of oxidized nicotinamide adenine dinucleotide, with sufficient water and no regeneration of the electron acceptor. At most $3\mu \mathrm{mol}$ can undergo the stated conversion. That would produce $3\mu \mathrm{mol}$ each of urate and reduced nicotinamide adenine dinucleotide, leaving $2\mu \mathrm{mol}$ xanthine. The smaller available stoichiometric amount limits this idealized reaction extent; more enzyme cannot supply the missing electron acceptor.

The electron acceptor also distinguishes the named activity from xanthine oxidase, which uses oxygen. The mammalian protein can convert between dehydrogenase and oxidase forms under particular conditions, including changes during purification; the names therefore describe experimentally distinguishable catalytic behavior rather than two entirely unrelated substrate names.^[ref]

A meaningful activity comparison must consequently specify both substrate and acceptor conditions. Loss of the NAD-dependent readout could reflect altered reaction conditions or enzyme form, rather than absence of the protein. Conversely, detecting a protein alone does not demonstrate a particular turnover rate. The chemical equation identifies what must be supplied and measured; enzyme kinetics determines how quickly the conversion proceeds.

Xanthine oxidase is an enzyme that oxidizes xanthine while using molecular oxygen as an electron acceptor. Its activity is classified as EC1.17.3.2. The IUBMB gives the overall reactionThe products are urate and hydrogen peroxide in this stated reaction. Other conditions can favor superoxide formation, so the equation does not specify every oxygen-reduction product in every assay.^[ref]

For an idealized peroxide-route inventory, four micromoles of xanthine and ten micromoles of molecular oxygen, with sufficient water and no competing reactions, can yield four micromoles each of urate and hydrogen peroxide. Six micromoles of molecular oxygen remain. This is a stoichiometric limit; it does not predict the reaction rate or completion under a particular set of conditions.

Xanthine dehydrogenase instead couples the oxidation to reduction of nicotinamide adenine dinucleotide. Mammalian enzyme preparations can convert between the two forms. A 2000 comparison determined bovine dehydrogenase and oxidase structures at $2.1\text{A˚}$ and $2.5\text{A˚}$, respectively. Changes near the flavin adenine dinucleotide region helped explain altered access of the NAD substrate and electron-acceptor preference.^[ref] Relating structure to both donor and acceptor chemistry is more informative than identifying the purine substrate alone.